J Obes Metab Syndr.
2022 Mar;31(1):86-87. 10.7570/jomes21094.
Letter: Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients (J Obes Metab Syndr 2021;30:149-54)
- Oh TJ
1,2
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
- KMID: 2527737
- DOI: http://doi.org/10.7570/jomes21094
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Letter: Psycho-Physiological Responses to a 4-Month High-Intensity Interval Training-Centered Multidisciplinary Weight-Loss Intervention in Adolescents with Obesity (J Obes Metab Syndr 2020;29:292-302)
- Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61-9)
- Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)
- Letter: Serum FGF21 Levels in Obese Korean Children and Adolescents (J Obes Metab Syndr 2017;26:204-9)
- Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients
